Diffusion Pharmaceuticals Inc. 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jan 4, 2017
Insider Transaction Report
Form 4
Byrne Thomas E
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2017-01-03+4,673→ 4,673 totalExercise: $2.26Exp: 2027-01-03→ Common Stock (4,673 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019.